|
|
||||||||
AJP - Lung Cellular and Molecular Physiology, Vol 262, Issue 4 482-L488, Copyright © 1992 by American Physiological Society
ARTICLES |
R. H. Simon, T. J. Gross, J. A. Edwards and R. G. Sitrin
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109.
The persistence of intra-alveolar fibrin during acute and chronic inflammatory lung diseases indicates that the normally profibrinolytic environment of the alveolar space has been altered as part of the disease process. We have recently shown that alveolar epithelial cells may control fibrinolysis by expressing both urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-1. In this study, monolayers of rat alveolar epithelial cells were used as a model of the alveolar surface and were found to lyse plasma-derived fibrin matrices by a process that was plasminogen and uPA dependent. Fibrinolysis was not achieved by fluid-phase epithelial products but required the presence of epithelial cells, optimally in close contact with the clot surface. Epithelial cell-mediated fibrinolytic activity was augmented 99% by endotoxin and suppressed 66% by dexamethasone. Fibrinolysis also increased 84% as cells aged in culture from day 1 to day 4, during which time the cells lose many type II cell characteristics and assume a type I cell-like phenotype. We conclude that alveolar epithelial cells actively participate in fibrin clearance through mechanisms that require close proximity between epithelial cell and clot surfaces. Alterations in these mechanisms may be partly responsible for the persistence of intraalveolar fibrin during lung inflammation.
This article has been cited by other articles:
![]() |
L. B. Ware and M. A. Matthay Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L924 - L940. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Murciano, D. Harshaw, D. G. Neschis, L. Koniaris, K. Bdeir, S. Medinilla, A. B. Fisher, M. A. Golden, D. B. Cines, M. T. Nakada, et al. Platelets inhibit the lysis of pulmonary microemboli Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L529 - L539. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. DOHI, T. HASEGAWA, K. YAMAMOTO, and B. C. MARSHALL Hepatocyte Growth Factor Attenuates Collagen Accumulation in a Murine Model of Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2302 - 2307. [Abstract] [Full Text] |
||||
![]() |
B. B. Moore, M. J. Coffey, P. Christensen, S. Sitterding, R. Ngan, C. A. Wilke, R. McDonald, S. M. Phare, M. Peters-Golden, R. Paine III, et al. GM-CSF Regulates Bleomycin-Induced Pulmonary Fibrosis Via a Prostaglandin-Dependent Mechanism J. Immunol., October 1, 2000; 165(7): 4032 - 4039. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wang, O. Ibarra-Sunga, L. Verlinski, R. Pick, and B. D. Uhal Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L143 - L151. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hattori, T. H. Sisson, Y. Xu, T. J. Desai, and R. H. Simon Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung Am J Physiol Lung Cell Mol Physiol, September 1, 1999; 277(3): L573 - L579. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hasegawa, L. Sorensen, H. Ooi, and B. C. Marshall Decreased Intracellular Iron Availability Suppresses Epithelial Cell Surface Plasmin Generation . Transcriptional and Post-transcriptional Effects on u-PA and PAI-1 Expression Am. J. Respir. Cell Mol. Biol., August 1, 1999; 21(2): 275 - 282. [Abstract] [Full Text] |
||||
![]() |
G. B. Toews Cellular Alterations in Fibroproliferative Lung Disease Chest, July 1, 1999; 116(2007): 112S - 116S. [Full Text] |
||||
![]() |
B. D. Uhal, C. Gidea, R. Bargout, A. Bifero, O. Ibarra-Sunga, M. Papp, K. Flynn, and G. Filippatos Captopril inhibits apoptosis in human lung epithelial cells: a potential antifibrotic mechanism Am J Physiol Lung Cell Mol Physiol, November 1, 1998; 275(5): L1013 - L1017. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |